Quarterly report · Q1
3583.TEDINET S100OWKG
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥154m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥148m | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥178m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥727m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥150m | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥231m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥150m | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥161m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥537m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥104m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥161m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥104m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥9.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥9.4bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥8.8bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.0bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.5bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.9bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥58.32 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥194.04 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.48 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.4% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥221,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥3m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥353m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥352m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥25m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥981m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥981m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥205m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥230m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥227m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥822,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥822,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥5m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥329m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥328m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥891,000 |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥36m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥973m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥973m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥190m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥891,000 |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥226m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥891,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥220m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 373
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ncl | Prior1YearInstant | 515000 | JPY |
| Other ncl | CurrentQuarterInstant | 515000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1710516000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 1734012000 | JPY |
| Liabilities | Prior1YearInstant | 4024729000 | JPY |
| Liabilities | CurrentQuarterInstant | 4015776000 | JPY |
| Capital stock | Prior1YearInstant | 1939834000 | JPY |
| Capital stock | CurrentQuarterInstant | 1939834000 | JPY |
| Capital surplus | Prior1YearInstant | 518489000 | JPY |
| Capital surplus | CurrentQuarterInstant | 518489000 | JPY |
| Retained earnings | Prior1YearInstant | 3109540000 | JPY |
| Retained earnings | CurrentQuarterInstant | 3108169000 | JPY |
| Treasury stock | Prior1YearInstant | -212795000 | JPY |
| Treasury stock | CurrentQuarterInstant | -210618000 | JPY |
| Shareholders equity | Prior1YearInstant | 5355068000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 5355875000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 35651000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 39178000 | JPY |
| Revaluation reserve for land | Prior1YearInstant | -39249000 | JPY |
| Revaluation reserve for land | CurrentQuarterInstant | 46577000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 65005000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 86404000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 61407000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 172161000 | JPY |
| Net assets | Prior1YearInstant | 5416476000 | JPY |
| Net assets | CurrentQuarterInstant | 5528036000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 9441206000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 9543813000 | JPY |
| Net sales | Prior1YTDDuration | 1301975000 | JPY |
| Net sales | CurrentYTDDuration | 1333010000 | JPY |
| Cost of sales | Prior1YTDDuration | 858853000 | JPY |
| Cost of sales | CurrentYTDDuration | 859317000 | JPY |
| Gross profit | Prior1YTDDuration | 443121000 | JPY |
| Gross profit | CurrentYTDDuration | 473693000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 295126000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 319249000 | JPY |
| Operating income | Prior1YTDDuration | 147994000 | JPY |
| Operating income | CurrentYTDDuration | 154444000 | JPY |
| Interest income noi | Prior1YTDDuration | 110000 | JPY |
| Interest income noi | CurrentYTDDuration | 150000 | JPY |
| Dividends income noi | Prior1YTDDuration | 1007000 | JPY |
| Dividends income noi | CurrentYTDDuration | 1668000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 3244000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 24967000 | JPY |
| Other noi | Prior1YTDDuration | 1190000 | JPY |
| Other noi | CurrentYTDDuration | 1250000 | JPY |
| Non operating income | Prior1YTDDuration | 5553000 | JPY |
| Non operating income | CurrentYTDDuration | 28036000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 3771000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 3304000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |